HARTFORD, Conn., Aug. 17, 2017 /Weed Wire/ — Tomorrow, on Friday, August 18th at 8:30am the Board of Physicians will hold a public hearing to discuss the addition of two conditions to the Medical Marijuana Program.
Tag Archives: Qualifying Conditions
On July 25, 2017, the New Jersey Medicinal Marijuana Program Review Panel revealed an initial recommendation to add migraines, Tourette’s Syndrome, chronic pain and anxiety to the list of qualifying conditions for those seeking medical marijuana treatment in the Garden State.
Today, the New Jersey Medicinal Marijuana Program Review Panel made initial recommendations to the Health Commissioner to approve chronic pain, migraine, anxiety and Tourette’s Syndrome as qualifying conditions for the medical marijuana program.
While recreational legalization failed recently in the Green Mountain State, the Vermont medical marijuana program is still making progress.
ATHENS, Greece, June 30, 2017 /Weed Wire/ — Published today in the Official Gazette, Joint Ministerial Decision (JMD) Ministers of Health and Justice, which opens the way for the introduction of approved medications and hemp products. These formulations are indicated for cases that have proven clinical benefit for a variety of diseases such as chronic pain, neuropathic pain, nausea and vomiting due to chemotherapy, cachexia / anorexia. etc.
Florida medical marijuana legislation has finally expanded the state’s medical marijuana program. On June 26, 2017, Florida Gov. Rick Scott signed into law SB 8-A, a bill that expands the state’s program by adding cultivators and qualifying conditions.
On June 7, 2017, the Florida legislature reached an agreement on rules regulating medical marijuana in the state. House Majority Leader Ray Rodrigues said that the two chambers of government had reached a “conceptual agreement” and that the House was currently reviewing the Senate’s proposed measure.
New Jersey might get an influx of new medical marijuana patients. On May 11, 2017, the New Jersey Medicinal Marijuana Program Review Panel suggested that the state health commissioner add chronic pain as a qualifying condition.
TRENTON, N.J., May 11, 2017 /Weed Wire/ — Today, the New Jersey Medicinal Marijuana Program Review Panel made initial recommendations to the Health Commissioner to approve chronic pain related to musculoskeletal disorders, migraines, anxiety, chronic fatigue related to ailments such as irritable bowel syndrome, Tourrette syndrome as qualifying conditions for the medical marijuana program.
On May 9, 2017, Georgia Gov. Nathan Deal signed Senate Bill 16, a medical cannabis expansion bill that adds six new conditions to the list of conditions that qualify for low-thc oil in the state.
On April 19, 2017, West Virginia Gov. Jim Justice signed Senate Bill 386, also known as the West Virginia Medical Cannabis Act, legalizing medical cannabis as a treatment option for patients suffering from one of several qualifying conditions.
Medical marijuana may soon be coming to the Mountain State. On March 29, 2017, the West Virginia Senate voted to approve Senate Bill 386, a bill that would legalize medical marijuana in the state.
On March 1, 2017, the Georgia House of Representatives voted to approve House Bill 65, which would expand the number of qualifying conditions covered by the state’s limited medical marijuana program.
On Feb. 8, 2017, the New Mexico Senate Judiciary Committee voted to endorse Senate Bill 8, a bill that would, among many other changes, allow United States military veterans residing in New Mexico to use medical marijuana, regardless of diagnosis.
On Feb. 7, 2017, Florida state officials hosted a public workshop in Fort Lauderdale on the state Department of Health’s proposed rules for Florida’s medical marijuana system.
On Jan. 18, 2017, Guam’s medical cannabis license applications were made available at the Department of Public Health and Social Services’ main office in Mangilao.
In South Carolina, Rep. Todd Rutherford has pre-filed a bill that would legalize medical marijuana in the state. Dubbed the Put Patients First Act, the bill would allow qualified patients to possess up to two ounces of medical marijuana as well grow up to six plants.
According to a survey released by the Ohio State Medical Board, only 30% of doctors in the state would be likely to recommend medical marijuana to patients with qualifying conditions.
Minnesota residents suffering from post-traumatic stress disorder will soon be able to use medical marijuana to treat their condition.
On Dec. 1, 2016, the New York State Department of Health announced that it will be adding chronic pain to the list of qualifying conditions for medical marijuana.
ST. PAUL, Minn., Dec. 1, 2016 /Weed Wire/ — Minnesota Commissioner of Health Dr. Ed Ehlinger today announced the decision to add post-traumatic stress disorder (PTSD) as a new qualifying condition for the state’s medical cannabis program.
On Nov. 8, 2016, a majority of voters in North Dakota approved Measure 5, legalizing medical marijuana in the state and signaling a watershed victory in the legalization movement.
On Nov. 8, 2016, Florida voters overwhelmingly voted to approve Amendment 2, a ballot amendment that will legalize medical marijuana in the state.
On Nov. 4, 2016, the Medical Cannabis Advisory Board to the New Mexico Medical Cannabis Program voted in favor of adding “opiate use disorder” to the state’s list of conditions that qualify for medical marijuana as a treatment option.
A law making medical marijuana legal in Ohio is now in effect.
Family members remember Robert Jester as a big man with a big presence, and on Wednesday, his story made a big difference to many terminally ill Delawareans.
On Aug. 30, 2016, the New York State Department of Health announced that it is going to expand its medical marijuana program.
The transparency of New York’s Medical Marijuana Program has been questioned by many New Yorkers, but on Aug. 19, 2016, the New York State Department of Health released a two-year report on the state’s Medical Use of Marijuana Under the Compassionate Care Act, as confirmed by a staff member with the NYS Medical Marijuana Program.
On August 3, 2016, state officials announced that Illinois patients spent $2,947,223 on medical marijuana in the month of July, beating out the previous month’s record high of $2.57 million.
TRENTON, N.J. (AP) – Republican Gov. Chris Christie will decide whether New Jersey residents with post-traumatic stress disorder can be treated with medical marijuana after lawmakers approved a measure Monday.
MINNEAPOLIS (AP) – Nearly 500 patients suffering intractable pain have registered to buy medical marijuana starting Monday.
The Arizona Department of Health Services is accepting medical marijuana dispensary applications from July 18 – July 29, 2016.
According to a letter dated July 8, 2016, the Maine Department of Health and Human Services has denied a petition by Dawson Julia, a medical marijuana caregiver, to add “Addiction to Opiates and drugs derived from chemical synthesis” to the state’s list of qualifying conditions for medical marijuana.
On July 13, 2016, Montana Sec. of State Linda McCulloch certified that Initiative 182, an initiative that would expand the availability of medical marijuana in the state, had received enough valid signatures to qualify for the state’s ballot in November.
On July 7, 2016, the Illinois Department of Agriculture announced that the state banked $2.57 million in retail sales for the month of June, which is a slight increase from the $2.3 million in retails sales for May.
If you have a medical condition that could possibly be treated with medical marijuana, the state of New Jersey wants to hear from you.
Lawmakers in the New Jersey Assembly voted 55 to 14 in favor of a bill that would add post-traumatic stress disorder (PTSD) to the list of accepted health conditions that qualify a patient to obtain medical marijuana in the state.
On June 6, 2016, the Minnesota Department of Health issued a report on survey results collected from patients in the state’s medical cannabis program, revealing that a majority of patients have benefited substantially from using legal medical cannabis.
On June 1, 2016, Joseph Wright, program coordinator for the Illinois Medical Cannabis Pilot Program, announced that registered dispensaries logged nearly $2.3 million in sales for the month of May, which is a slightly increase from April’s sales total of $2.2 million.
On May 31, 2016, the Illinois state senate voted to approve Senate Bill 10, a bill that would update the state’s medical marijuana laws.
On May 19, 2016, Gov. John Bel Edwards signed Senate Bill 271, expanding the number of qualifying conditions for the state’s medical marijuana program and regulatory improvements to expedite access, as well as adding language to protect physicians, according to WAFB News.
On May 11, 2016, the Louisiana House of Representatives voted to approve SB 271, a bill designed to help kick start the state’s sputtering medical marijuana program.
On May 5, 2016, the Ohio House Select Committee on Medical Marijuana voted to clear HB 523, a bill that would legalize medical marijuana in the state of Ohio.
On May 3, 2016, the Louisiana House Health and Welfare Committee voted 8-6 approve SB 271, which, among other things, would expand the number of qualifying conditions for the state’s limited medical marijuana program.
On May 2, 2016, the Illinois Medical Cannabis Advisory Board met to review a request to expand the state’s number of qualifying conditions. According to the Associated Press, the board voted to recommend diabetes and panic disorder as qualifying conditions.
On Monday, May 2, 2016, the Illinois Medical Cannabis Advisory Board will meet to discuss the possibility of approving additional conditions for the state’s list of conditions that can qualify a patient to use medical cannabis.
On April 20, 2016, the Louisiana State Senate voted to approve a bill that would expand the number of qualifying conditions for the state’s limited medical marijuana program.
In Maine, medical marijuana activists are hoping to convince state lawmakers to expand the state’s list of qualifying conditions to include one of the most pressing medical conditions in the United States: opioid addiction.
On April 13, 2016, the Pennsylvania House of Representatives passed SB3, a bill legalizing medical marijuana in the state, and then sent the bill to Gov. Tom Wolf to sign. Wolf officially signed SB3 into law on April 17.
On April 13, 2016, the Pennsylvania House of Representatives passed SB3, a bill legalizing medical marijuana in the state, and has sent the bill to Gov. Tom Wolf to sign.